GETECCU position paper on fragility, advanced age and inflammatory bowel disease

Frailty is a state of vulnerability characterised by a decrease in physiological reserve and the ability to respond to stress, which increases the risk of complications, adverse effects of treatments and functional decline. Assessing frailty allows the biological age of patients to be determined, be...

Descripción completa

Detalles Bibliográficos
Autores: Mañosa, M, Calafat, M, Francia, E, Riba, F, Mesonero, F, Suárez, C, Garcia-Lopez, S, Losfablos, F, Calvet, X, Domènech, E, Casbas, AG, Ordás, I, Menchén, L, Rodríguez-Moranta, F, Zabana, Y
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
Repositorio:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
OAI Identifier:oai:dnet:isabial_____::fee191cdab6be18183fd849df475e59d
Acceso en línea:https://isabial.portalinvestigacion.com/publicaciones12550
https://www.sciencedirect.com/science/article/pii/S0210570525003991?pes=vor&utm_source=clarivate&getft_integrator=clarivate
Access Level:acceso abierto
Palabra clave:Inflammatory bowel disease
Crohn's disease
Ulcerative colitis
Frailty
Elderly
id ES_fb297fc8a7b7a7e813c02c5ce80b3ffb
oai_identifier_str oai:dnet:isabial_____::fee191cdab6be18183fd849df475e59d
network_acronym_str ES
network_name_str España
repository_id_str
spelling GETECCU position paper on fragility, advanced age and inflammatory bowel diseaseMañosa, MCalafat, MFrancia, ERiba, FMesonero, FSuárez, CGarcia-Lopez, SLosfablos, FCalvet, XDomènech, ECasbas, AGOrdás, IMenchén, LRodríguez-Moranta, FZabana, YInflammatory bowel diseaseCrohn's diseaseUlcerative colitisFrailtyElderlyFrailty is a state of vulnerability characterised by a decrease in physiological reserve and the ability to respond to stress, which increases the risk of complications, adverse effects of treatments and functional decline. Assessing frailty allows the biological age of patients to be determined, beyond their chronological age, providing a more accurate picture of their health status and care needs. The proportion of older adults with IBD is increasing in parallel with the ageing of the general population, and it is estimated that in the next decade, more than a third of IBD patients will be over 60 years of age. This population may suffer from complications arising from previously developed IBD and is particularly susceptible to developing side effects from treatment, making comprehensive assessment essential in order to identify those who are most vulnerable. Frailty is compounded by other geriatric syndromes such as comorbidity and polypharmacy, which can significantly interfere with the management and course of IBD, influencing the therapeutic strategy and prognosis. Objective In this context, comprehensive geriatric assessment should be systematic in elderly patients with IBD, with the aim of detecting functional deficits and implementing specific interventions for nutritional support, functional rehabilitation and psychological care to optimise their progress. This position paper aims to establish recommendations in this regard based on the available evidence. Conclusions The systematic incorporation of comprehensive geriatric assessment in the management of older people with IBD represents an essential strategy for improving clinical outcomes, adapting treatments to the patient's functional capacity and promoting a truly person-centred approach.ELSEVIER ESPANA SLU2025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://isabial.portalinvestigacion.com/publicaciones12550https://www.sciencedirect.com/science/article/pii/S0210570525003991?pes=vor&utm_source=clarivate&getft_integrator=clarivateGastroenterologia y HepatologiaISSN: 02105705reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicanteinstname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)Españolinfo:eu-repo/semantics/openAccessoai:dnet:isabial_____::fee191cdab6be18183fd849df475e59d2026-06-12T10:20:37Z
dc.title.none.fl_str_mv GETECCU position paper on fragility, advanced age and inflammatory bowel disease
title GETECCU position paper on fragility, advanced age and inflammatory bowel disease
spellingShingle GETECCU position paper on fragility, advanced age and inflammatory bowel disease
Mañosa, M
Inflammatory bowel disease
Crohn's disease
Ulcerative colitis
Frailty
Elderly
title_short GETECCU position paper on fragility, advanced age and inflammatory bowel disease
title_full GETECCU position paper on fragility, advanced age and inflammatory bowel disease
title_fullStr GETECCU position paper on fragility, advanced age and inflammatory bowel disease
title_full_unstemmed GETECCU position paper on fragility, advanced age and inflammatory bowel disease
title_sort GETECCU position paper on fragility, advanced age and inflammatory bowel disease
dc.creator.none.fl_str_mv Mañosa, M
Calafat, M
Francia, E
Riba, F
Mesonero, F
Suárez, C
Garcia-Lopez, S
Losfablos, F
Calvet, X
Domènech, E
Casbas, AG
Ordás, I
Menchén, L
Rodríguez-Moranta, F
Zabana, Y
author Mañosa, M
author_facet Mañosa, M
Calafat, M
Francia, E
Riba, F
Mesonero, F
Suárez, C
Garcia-Lopez, S
Losfablos, F
Calvet, X
Domènech, E
Casbas, AG
Ordás, I
Menchén, L
Rodríguez-Moranta, F
Zabana, Y
author_role author
author2 Calafat, M
Francia, E
Riba, F
Mesonero, F
Suárez, C
Garcia-Lopez, S
Losfablos, F
Calvet, X
Domènech, E
Casbas, AG
Ordás, I
Menchén, L
Rodríguez-Moranta, F
Zabana, Y
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Inflammatory bowel disease
Crohn's disease
Ulcerative colitis
Frailty
Elderly
topic Inflammatory bowel disease
Crohn's disease
Ulcerative colitis
Frailty
Elderly
description Frailty is a state of vulnerability characterised by a decrease in physiological reserve and the ability to respond to stress, which increases the risk of complications, adverse effects of treatments and functional decline. Assessing frailty allows the biological age of patients to be determined, beyond their chronological age, providing a more accurate picture of their health status and care needs. The proportion of older adults with IBD is increasing in parallel with the ageing of the general population, and it is estimated that in the next decade, more than a third of IBD patients will be over 60 years of age. This population may suffer from complications arising from previously developed IBD and is particularly susceptible to developing side effects from treatment, making comprehensive assessment essential in order to identify those who are most vulnerable. Frailty is compounded by other geriatric syndromes such as comorbidity and polypharmacy, which can significantly interfere with the management and course of IBD, influencing the therapeutic strategy and prognosis. Objective In this context, comprehensive geriatric assessment should be systematic in elderly patients with IBD, with the aim of detecting functional deficits and implementing specific interventions for nutritional support, functional rehabilitation and psychological care to optimise their progress. This position paper aims to establish recommendations in this regard based on the available evidence. Conclusions The systematic incorporation of comprehensive geriatric assessment in the management of older people with IBD represents an essential strategy for improving clinical outcomes, adapting treatments to the patient's functional capacity and promoting a truly person-centred approach.
publishDate 2025
dc.date.none.fl_str_mv 2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://isabial.portalinvestigacion.com/publicaciones12550
https://www.sciencedirect.com/science/article/pii/S0210570525003991?pes=vor&utm_source=clarivate&getft_integrator=clarivate
url https://isabial.portalinvestigacion.com/publicaciones12550
https://www.sciencedirect.com/science/article/pii/S0210570525003991?pes=vor&utm_source=clarivate&getft_integrator=clarivate
dc.language.none.fl_str_mv Español
language_invalid_str_mv Español
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv ELSEVIER ESPANA SLU
publisher.none.fl_str_mv ELSEVIER ESPANA SLU
dc.source.none.fl_str_mv Gastroenterologia y Hepatologia
ISSN: 02105705
reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
instname_str Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
reponame_str r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
collection r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869425304123998208
score 15,81155

Similares en LA Referencia